Original articleChronic heart failure and risk of hospitalization with pneumonia: A population-based study
Introduction
Hospitalizations with pneumonia have increased by up to 50% in Western populations during the past 15 years [1], [2], [3], and pneumonia is a leading cause of death [4], [5], [6]. The prevalence of many chronic diseases has increased because of lifestyle factors, population aging, and longer disease survival [7]. This increase is expected to contribute to a further rise in pneumonia hospitalizations, both in the Western world [8] and in developing countries [9].
Chronic heart failure may be a major risk factor for hospitalization with pneumonia, yet population-based studies on this association are few [10], [11], [12], [13], [14], [15]. Persons with heart failure may have increased susceptibility to severe pneumonia for several reasons [8]. Alveoli flooding may interfere with normal physiological mechanisms operating in the alveolar lining fluid at the interphase between air and the lung tissue (including effective opsonins and macrophages), thus hampering microbial clearance and increasing the risk of bacterial infection [16]. Also, pneumonia may induce or worsen heart failure and cardiogenic pulmonary edema as cardiac output fails to meet the needs during infection, increasing the risk of being hospitalized with pneumonia [1].
A few cohort and case–control studies have included heart failure on a list of predictors for pneumonia, with widely varying relative risk estimates between 1.5 and 3.8 [11], [12], [13], [17]. Studies on the effect of the severity of heart failure on the risk of pneumonia are, to our knowledge, absent. Bearing in mind that pre-existing heart failure increases risk of death following pneumonia by 30–50% [8], [18], [19], it is important to investigate heart failure as risk factor for pneumonia and to clarify which patients are at particularly increased risk. We undertook a large population-based case–control study to assess these associations.
Section snippets
Materials and methods
We conducted this study in the Danish counties of North Jutland and Aarhus, with a mixed rural and urban population of approximately 1.15 million people. The Danish National Health service provides tax-supported health care for all residents, including free access to primary care and hospitals, and reimbursement of a portion of the cost of most prescription drugs [20]. Civil registration numbers, unique identifiers assigned to each Danish citizen, which encode birth date and sex, allow accurate
Descriptive data
We identified 67,162 patients with a first incident pneumonia-related hospitalization and 671,620 population controls (Table 1). The study population was 53% male and 47% female, with a median age of 73 (interquartile range 60 to 81) years. A total of 12,339 pneumonia cases (18.4%) and 53,989 controls (8.0%) had a previous diagnosis of heart failure. Compared with their age-matched population controls, pneumonia cases were much more likely to have a history of any hospital-diagnosed comorbidity
Discussion
Our large population based study of more than 67,000 patients with pneumonia provides robust evidence that patients with chronic heart failure have an almost doubled risk of hospitalization with pneumonia compared with other individuals. Heart failure patients with cardiomyopathy and heart valve disease and those who used loop-diuretics for therapy were at particularly increased risk.
The results of our population-based study are consistent with previous observations of increased risk of
Learning points
- •
In a large and unselected population of all ages, patients with chronic heart failure had an almost doubled risk of hospitalization with pneumonia, compared with other individuals.
- •
Patient use of loop-diuretics, and the presence of cardiomyopathy or heart valve disease are predictors of particularly increased pneumonia risk.
- •
Clinicians should remain vigilant for the risk of pneumonia in heart failure patients, and further studies should elucidate modifiable risk factors for pneumonia in this
Funding source
This study was supported by the Karen Elise Jensen Foundation and the Clinical Epidemiological Research Foundation, Denmark. The Department of Clinical Epidemiology is a member of the Danish Centre for Strategic Research in Type 2 Diabetes (the Danish Research Council, grant nos. 09-075724 and 10-079102).
Conflict of interests
None of the authors received any fees, honoraria, grants or consultancies that would constitute a conflict of interest with the current study. The Department of Clinical Epidemiology, Aarhus University Hospital, receives funding for other studies from companies in the form of research grants to (and administered by) Aarhus University; none of these studies has any relation to the present study.
Ethics approval
As this study did not involve any contact with patients or any intervention, according to Danish law it was not necessary to obtain permission from the Danish Scientific Ethical Committee.
Acknowledgments
None.
References (39)
- et al.
The management of patients with community-acquired pneumonia beyond antibiotic therapy
Eur J Intern Med
(2012) - et al.
Risk factors for pneumonia in the elderly
Am J Med
(1994) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)
J Am Coll Cardiol
(2005)- et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chronic Dis
(1987) - et al.
2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults A report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation
J Am Coll Cardiol
(2009) - et al.
Can we use severity assessment tools to increase outpatient management of community-acquired pneumonia?
Eur J Intern Med
(2012) - et al.
Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark
J Intern Med
(2006) - et al.
Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988–2002
JAMA
(2005) - et al.
Increasing hospital admissions for pneumonia, England
Emerg Infect Dis
(2008) Vital statistics data available online
Hospital standardised mortality ratios based on data from administrative registries. A pilot project
Ugeskr Laeger
Social participation and healthy ageing: a neglected, significant protective factor for chronic non communicable conditions
Global Health
The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study
J Gen Intern Med
Global status report on non-communicable diseases
The burden of community-acquired pneumonia in seniors: results of a population-based study
Clin Infect Dis
Hospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival
J Am Geriatr Soc
Risk factors for acquiring pneumococcal infections
Arch Intern Med
Risk factors for death and hospitalization from pneumonia. A prospective study of a general population
Eur Respir J
Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community
Respir Med
Cited by (41)
ACDD<sup>4</sup> score: A simple tool for assessing risk of pneumonia after stroke
2017, Journal of the Neurological SciencesCitation Excerpt :CHF may increase risk of pneumonia due to alveolar congestion and reduced microbial clearance [17]. Population based studies have shown that CHF can increase the risk for pneumonia; the effect estimates from our cohort parallel findings from these studies [18,19]. Incorporation of dysarthria is another novel score item in the ACDD4 scoring system.
Acinetobacter baumannii among Patients Receiving Glucocorticoid Aerosol Therapy during Invasive Mechanical Ventilation, China
2022, Emerging Infectious DiseasesDiuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions—Part II: Combination Therapy
2024, Current Heart Failure ReportsDeveloping a Preliminary Clinical Prediction Model for Prognosis of Pneumonia Complicated with Heart Failure Based on Metagenomic Sequencing
2023, Critical Care Research and Practice